Engineered microparticles based on drug–polymer coprecipitates for ocular-controlled delivery of Ciprofloxacin: influence of technological parameters

References

• Teng W, Cappello J, Wu W. Physical crosslinking modulates sustained drug release from recombinant silk-elastin like protein polymer for ophthalmic applications. J Control Release 2011;156:186–94
   PubMed Web of Science ®Google Scholar
• Blondeau JM. Fluoroquinolones: mechanism of action, classification, and development of resistance. Surv Ophthalmol 2004;49:S73–8
   PubMed Web of Science ®Google Scholar
• Diamond JP, White L, Leeming JP, et al. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol 1995;79:606–9
   PubMed Web of Science ®Google Scholar
• Sanfilippo CM, Morrissey I, Janes R, Morris TW. Surveillance of the activity of aminoglycosides and fluoroquinolones against ophthalmic pathogens from Europe in 2010–2011. Curr Eye Res 2015;22:1–9
   Web of Science ®Google Scholar
• Montero MT, Vazquez JL, Hernandez-Borrell J, Keough KMW. Location of Ciprofloxacin alkyl-derivatives in model membranes studied by fluorimetric techniques. In: Carmona P, Navarro R, Hernanz A, eds. Spectroscopy of biological molecules: modern trends. Dordrecht, Netherlands: Kluwer Academic Publishers; 1997:311–12
   Google Scholar
• Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present, and future perspectives. Int J Antimicrob Agents 2000;16:5–15
   PubMed Web of Science ®Google Scholar
• Campoli-Richards DM, Monk JP, Price A, et al. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1988;35:373–447
   PubMed Web of Science ®Google Scholar
• Mundada AS, Shrikhande BK. Formulation and evaluation of Ciprofloxacin hydrochloride soluble ocular drug insert. Curr Eye Res 2008;33:469–75
   PubMed Web of Science ®Google Scholar
• Parks DJ, Abrams DA, Sarfarazi FA, Katz HR. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol 1993;115:471–7
   PubMed Web of Science ®Google Scholar
• Firestone BA, Dickason MA, Tran T. Solubility characteristics of three fluoroquinolone ophthalmic solutions in an in vitro tear model. Int J Pharm 1998;164:119–28
   Web of Science ®Google Scholar
• Abdelbary G, El-Gendy N. Niosome-encapsulated Gentamicin for ophthalmic controlled delivery. AAPS Pharm Sci Tech 2008;9:740–7
   PubMed Web of Science ®Google Scholar
• Sintzel MB, Bernatchez SF, Tabatabay C, Gurny R. Biomaterials in ophthalmic drug delivery. Eur J Pharm Biopharm 1996;42:358–74
   Web of Science ®Google Scholar
• Rozier A, Mazuel C, Grove J, Plazonnet B. Gelrite: a novel, ion-activated, in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of Timolol. Int J Pharm 1989;57:163–8
   Web of Science ®Google Scholar
• Budai L, Hajdu M, Budai M, et al. Gels and liposomes in optimized ocular drug delivery: studies on Ciprofloxacin formulations. Int J Pharm 2007;343:34–40
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm 2004;269:1–14
   PubMed Web of Science ®Google Scholar
• Hosny KM. Ciprofloxacin as ocular liposomal hydrogel. AAPS Pharm Sci Tech 2010;11:241–6
   PubMed Web of Science ®Google Scholar
• Taha EI, El-Anazi MH, Mel-Bagory I, Bayomi MA. Design of liposomal colloidal systems for ocular delivery of Ciprofloxacin. Saudi Pharm J 2014;22:231–9
   PubMed Web of Science ®Google Scholar
• Li H, Liu Y, Zhang Y, et al. Liposomes as a novel ocular delivery system for Brinzolamide: in vitro and in vivo studies. AAPS Pharm Sci Tech 2015. [Epub ahead of print]. doi: 10.1208/S12249-015-0382-1
   Web of Science ®Google Scholar
• Chetoni P, Monti D, Tampucci S, et al. Liposomes as a potential ocular delivery system of Distamycin A. Int J Pharm 2015;492:120–6
   PubMed Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 2011;16:44–56
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Deshmukh SR. Development and evaluation of gel-forming ocular films based on xyloglucan. Carbohydr Polym 2015;122:243–7
   PubMed Web of Science ®Google Scholar
• Huang YY Chung TW. Microencapsulation of gentamicin in biodegradable PLA and/or PLA/PEG copolymer. J Microencapsul 2001;18:457–65
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Conte U, Chetoni P, Saettone MF. Pectin microspheres as ophthalmic carriers for Piroxicam: evaluation in vitro and in vivo in albino rabbits. Eur J Pharm Sci 1999;9:1–7
   PubMed Web of Science ®Google Scholar
• Giunchedi P, Chetoni P, Conte U, Saettone MF. Albumin microspheres for ocular delivery of Piroxicam. Pharm Pharmacol Commun 2000;6:149–53
   Google Scholar
• Gavini E, Chetoni P, Cossu M, et al. PLGA microspheres for the ocular delivery of a peptide drug, Vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur J Pharm Biopharm 2004;57:207–12
   PubMed Web of Science ®Google Scholar
• Rassu G, Gavini E, Jonassen H, et al. New chitosan derivatives for the preparation of Rokitamycin loaded microspheres designed for ocular or nasal administration. J Pharm Sci 2009;98:4852–65
   PubMed Web of Science ®Google Scholar
• Park CG, Kim MJ, Park M, et al. Nanostructured mucoadhesive microparticles for enhanced preocular retention. Acta Biomater 2014;10:77–86
   PubMed Web of Science ®Google Scholar
• Shinde UA, Shete JN, Nair HA, Singh KH. Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine. Pharm Dev Technol 2014;19:813–23
   PubMed Web of Science ®Google Scholar
• Addo RT, Yeboah KG, Siwale RC, et al. Formulation and characterization of atropine sulfate in albumin-chitosan microparticles for in vivo ocular drug delivery. J Pharm Sci 2015;104:1677–90
   PubMed Web of Science ®Google Scholar
• Cadinoiu AN, Peptu CA, Fache B, et al. Microparticulated systems based on chitosan and poly(vinyl alcohol) with potential ophthalmic applications. J Microencapsul 2015;32:381–9
   PubMed Web of Science ®Google Scholar
• Jani R, Gan O, Ali Y, et al. Ion exchange resins for ophthalmic delivery. J Ocul Pharmacol 1994;10:57–67
   PubMedGoogle Scholar
• Li J, Liu H, Liu LL, et al. Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery. Chem Pharm Bull 2014;62:1000–8
   PubMed Web of Science ®Google Scholar
• Qin F, Zeng L, Zhu Y, et al. Preparation and evaluation of a timolol maleate drug-resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo. Drug Dev Ind Pharm 2015;1–11. [Epub ahead of print]. doi: 10.3109/03639045.2015.1085872
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Chetoni P, Giunchedi P, et al. Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies. Eur J Pharm Biopharm 2004;57:465–72
   PubMed Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Chetoni P, et al. Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization. Eur J Pharm Biopharm 2006;62:59–69
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Sandri G, Gavini E, et al. Microparticle systems based on polymer-drug interaction for ocular delivery of ciprofloxacin I. In vitro characterization. J Drug Del Sci Tech 2007;17:57–62
   Web of Science ®Google Scholar
• Bonferoni MC, Sandri G, Chetoni P, et al. Microparticle systems based on polymer-drug interaction for ocular delivery of ciprofloxacin II. Precorneal residence times. J Drug Del Sci Tech 2007;17:63–8
   Web of Science ®Google Scholar
• Verschueren E, VanSantvliet L, Ludwig A. Evaluation of various carrageenans as ophthalmic viscolysers. STP Pharma Sci 1996;6:203–10
   Google Scholar
• Moon JW, Lee HJ, Shin KC, et al. Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye. Korean J Ophthalmol 2007;21:189–94
   PubMedGoogle Scholar
• Baranowski P, Karolewicz B, Gajda M, Pluta J. Ophthalmic drug dosage forms: characterisation and research methods. ScientificWorld J 2014;2014:861904. doi: 10.1155/2014/861904
   PubMed Web of Science ®Google Scholar
• Qi H, Chen W, Huang C, et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 2007;337:178–87
   PubMed Web of Science ®Google Scholar
• Aburahma MH, Mahmoud AA. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation. AAPS Pharm Sci Tech 2011;12:1335–47
   PubMed Web of Science ®Google Scholar
• Sandri G, Rossi S, Ferrari F, et al. Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum. J Pharm Pharmacol 2004;56:1083–90
   PubMed Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Ferrari F, et al. An in situ gelling buccal spray containing platelet lysate for the treatment of oral mucositis. Curr Drug Discov Technol 2011;8:277–85
   PubMedGoogle Scholar
• Edmundson IC. Particle-size analysis. In: Bean HS, Carless JE, Beckett AH, eds. Advances in pharmaceutical sciences. Vol. 2. New York, NY: Academic Press;1967:95–179
   Google Scholar
• Gavini E, Rassu G, Muzzarelli C, et al. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of Metoclopramide. Eur J Pharm Biopharm 2008;68:245–52
   PubMed Web of Science ®Google Scholar
• Rassu G, Gavini E, Spada G, Giunchedi P. Ketoprofen spray-dried microspheres based on Eudragit RS and RL: study of the manufacturing parameters. Drug Dev Ind Pharm 2008;34:1178–87
   PubMed Web of Science ®Google Scholar
• Sahoo S, Chakraborti CK Mishra SC. Qualitative analysis of controlled release Ciprofloxacin/Carbopol 934 mucoadhesive suspension. J Adv Pharm Technol Res 2011;2:195–204
   PubMedGoogle Scholar
• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS Pharm Sci Tech 2009;10:808–19
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Yasueda S, Isowaki A, et al. Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. Int J Pharm 2005;301:121–8
   PubMed Web of Science ®Google Scholar
• Alany RG, Tucker IG, Davies NM, Rades T. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm 2001;27:31–8
   PubMed Web of Science ®Google Scholar